Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth of drugs such as ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Leerink Partnrs lifted their Q2 2025 earnings estimates for shares of AbbVie in a research report issued to clients and investors ...

AbbVie expects full-year earnings in the range of $12.09 to $12.29 per share. AbbVie shares have increased 1.5% since the beginning of the year, while the S&P's 500 index has declined nearly 7%.

AbbVie expects full-year earnings in the range of $12.09 to $12.29 per share. AbbVie shares have increased 1.5% since the beginning of the year, while the S&P's 500 index has declined nearly 7%.

AbbVie expects full-year earnings in the range of $12.09 to $12.29 per share. AbbVie shares have increased 1.5% since the beginning of the year, while the S&P's 500 index has declined nearly 7%.

AbbVie (NYSE:ABBV) is scheduled to announce its earnings on Friday, April 25, 2025. Currently, the company holds a market capitalization of $307 billion. Over the past twelve months, AbbVie ...

AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a report released on Tuesday ...

Live Updates Live Coverage Has Ended Deep Dive into ABBV's Earnings Call 11:53 am by Rich Duprey Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set ...

The market expects AbbVie (ABBV) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...